0001209191-19-020142.txt : 20190318
0001209191-19-020142.hdr.sgml : 20190318
20190318200654
ACCESSION NUMBER: 0001209191-19-020142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190314
FILED AS OF DATE: 20190318
DATE AS OF CHANGE: 20190318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANNETT WILLIAM
CENTRAL INDEX KEY: 0001662553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 19689882
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE, SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-775-0515
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-14
0
0001642380
OncoCyte Corp
OCX
0001662553
ANNETT WILLIAM
1010 ATLANTIC AVENUE
SUITE 102
ALAMEDA
CA
94501
1
1
0
0
President and CEO
Option to Purchase Common Stock
3.52
2019-03-14
4
A
0
390000
0.00
A
2029-03-13
Common Stock
390000
390000
D
One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on March 14, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date.
/s/William Annett
2019-03-18